Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 444, 256-257 (16 November 2006) | doi:10.1038/444256a; Published online 15 November 2006
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
- More Challenges
- Powered by:
nature jobs
PhD Programs
- Georg-August-Universitat Gottingen
- Göttingen, Germany
Senior Analyst - SCI
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
The chips are down
Abstract
Geneticists' desire to track the roots of complex diseases has shaken up the market for gene chips. Meredith Wadman reports on two firms jostling for position in a business potentially worth US$500 million.
Wall Street analyst Elise Wang began her coverage of the Goliath of gene-chip makers last month with an unequivocal recommendation: sell.Her advice came despite the fact that shares in Affymetrix, the company based in Santa Clara, California, whose scientists invented the gene chip 17 years ago, are already trading down by almost 50% from where they were a year ago (see graph).
To read this story in full you will need to login or make a payment (see right).
